Protara Therapeutics, Inc. TARA
Set alert
2.41 USD 0.00 0.00%
At close
2.49 +0.08 +3.32%
Pre-market · Nov 3, 8:41 AM ET
Day range unavailable
2.28 52-week range 7.82
- YTD
- -54.78%
- 1 year
- -53.47%
- Open
- —
- Prev close
- 2.41
- Mkt cap
- 142.42M
- Vol
- 0
- Avg vol
- 979.52K
- EPS
- -1.36
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.61
- Beta
- 1.79
- Short ratio
- 14.46
- Inst. own
- 51.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.22
- 200-d avg
- 2.74
- 1y target
- 26.40
MAX chart
Events in this range
- Aug 3, 2023Earnings: -1; estimate -0.97; surprise -3.09%
- Nov 3, 2023Earnings: -0.87; estimate -1.1; surprise 20.91%
- May 2, 2024Earnings: -0.97; estimate -0.99; surprise 2.02%
- May 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Aug 6, 2024Earnings: -0.45; estimate -0.82; surprise 45.12%
- Dec 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 6, 2024Rating: Guggenheim · Buy → Buy
Signals (26)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Jan 1, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
| SMA: Bearish | Jul 1, 2020 | 6 years ago |
| SMA: Bullish | Dec 1, 2019 | 6 years ago |
| SMA: Bearish | Mar 1, 2019 | 7 years ago |
| SMA: Bearish | Mar 1, 2019 | 7 years ago |
| SMA: Bullish | Feb 1, 2019 | 7 years ago |
| SMA: Bullish | Dec 1, 2018 | 7 years ago |
| SMA: Bearish | Sep 1, 2018 | 8 years ago |
Newest 20 of 26.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.40 +995.4% upside
Now 2.41
- Target (low)
- 14.00
- Target (mean)
- 26.40
- Target (high)
- 50.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 4
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.54333 | -0.61 – -0.51 | -0.90 | +39.6% | 0 | 0.0% | 3 |
| Next quarter | -0.62 | -0.67 – -0.55 | -0.97 | +36.1% | 0 | 0.0% | 3 |
| Current year | -2.30 | -2.38 – -2.22 | -3.57 | +35.6% | 0 | 0.0% | 3 |
| Next year | -2.28 | -2.67 – -1.54 | -2.30 | +0.7% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Guggenheim | Reiterated | Buy | Buy |
| Dec 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 8, 2021 | Oppenheimer | Maintained | — | Outperform |
| Jun 4, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 19, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Jul 29, 2020 | Guggenheim | Initiated | — | Buy |